Inhibitory effect of high [Mg2+] on the vasopressin-stimulated hydroosmotic permeability of the isolated perfused cortical collecting duct

Inhibitory effect of high [Mg2+] on the vasopressin-stimulated hydroosmotic permeability of the isolated perfused cortical collecting duct

High magnesium concentration inhibits the effect of arginine vasopressin (AVP) on smooth muscle contraction and platelet aggregation and also influences hepatocyte AVP receptor binding. The aim of this study was to determine the role of magnesium concentration [Mg2+] in AVP-stimula...

Full description

Bibliographic Details
Main Authors:	D. Falkenstein, C.A.L. Ribeiro, J.F. Figueiredo
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 1999-08-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	cortical collecting ducts magnesium arginine vasopressin osmotic water permeability
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000800016

Similar Items

Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01)

Effects of arginine vasopressin on the urine proteome in rats
by: Manxia An, et al.
Published: (2017-05-01)

Vasopressin and septic shock
by: Sarah Mousavi
Published: (2015-10-01)

Glucocorticoid Receptor Maintains Vasopressin Responses in Kidney Collecting Duct Cells
by: Hsiu-Hui Yang, et al.
Published: (2022-05-01)

Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment
by: Youko Ikeda, et al.
Published: (2022-06-01)

Evaluation of capillary leakage after vasopressin resuscitation in a hemorrhagic shock model
by: Roberto Bini, et al.
Published: (2018-03-01)

The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
by: Karol Chojnowski, et al.
Published: (2023-01-01)

Vasopressin-Independent Regulation of Aquaporin-2 by Tamoxifen in Kidney Collecting Ducts
by: Stine Julie Tingskov, et al.
Published: (2019-08-01)

International Survey on the Use of Arginine Vasopressin in the Postoperative Management of Single Ventricle Patients
by: Vidya R. Raghavan, et al.
Published: (2021-07-01)

Transcription Factor Elf3 Modulates Vasopressin-Induced Aquaporin-2 Gene Expression in Kidney Collecting Duct Cells
by: Shu-Ting Lin, et al.
Published: (2019-10-01)

Natura Non Facit Saltus: The Adaptive Significance of Arginine Vasopressin in Human Affect, Cognition, and Behavior
by: Bernard Crespi, et al.
Published: (2022-05-01)

Examining the significance of arginine vasopressin release to elucidate the often multifactorial etiology of hypotonic hyponatremia: A novel criterion
by: Philip J. G. M. Voets
Published: (2024-04-01)

Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency
by: Ho Kang, et al.
Published: (2024-02-01)

Arginine vasopressin injection rescues delayed oviposition in cyp19a1b-/- mutant female zebrafish
by: Katherine Shaw, et al.
Published: (2023-12-01)

Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment
by: Argelia Calvillo-Robledo, et al.
Published: (2023-03-01)

A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin
by: Gaurang P Mavani, et al.
Published: (2015-03-01)

Arginine vasopressin modulates electrical activity and calcium homeostasis in pulmonary vein cardiomyocytes
by: Jen-Hung Huang, et al.
Published: (2019-09-01)

The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment
by: Bo Zhou, et al.
Published: (2022-03-01)

Hyponatremia Associated with Congestive Heart Failure: Involvement of Vasopressin and Efficacy of Vasopressin Receptor Antagonists
by: San-e Ishikawa, et al.
Published: (2023-02-01)

Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes
by: A. Nesen, et al.
Published: (2022-06-01)

Sex-specific issues of central and peripheral arginine-vasopressin concentrations in neurocritical care patients
by: A. H. Podtschaske, et al.
Published: (2022-11-01)

α-Actinin 4 Links Vasopressin Short-Term and Long-Term Regulation of Aquaporin-2 in Kidney Collecting Duct Cells
by: Cheng-Hsuan Ho, et al.
Published: (2021-12-01)

Effect of arginine vasopressin on systemic and pulmonary arterial pressure in a patient with pulmonary hypertension secondary to pulmonary emphysema: a case report
by: Toshiyuki Mizota, et al.
Published: (2017-01-01)

Transcription Factor TonEBP Stimulates Hyperosmolality-Dependent Arginine Vasopressin Gene Expression in the Mouse Hypothalamus
by: Dong Hee Kim, et al.
Published: (2021-03-01)

Role of vasopressin in current anesthetic practice
by: Keun Suk Park, et al.
Published: (2017-06-01)

Synthesis and Biological Evaluation of Substituted Desloratadines as Potent Arginine Vasopressin V2 Receptor Antagonists
by: Shuai Mu, et al.
Published: (2014-02-01)

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
by: Mladena Glavaš, et al.
Published: (2022-03-01)

Assessment of Tissue Expression of the Oxytocin–Vasopressin Pathway in the Placenta of Women with a First-Episode Psychosis during Pregnancy
by: Miguel A. Ortega, et al.
Published: (2023-06-01)

Management of Hyponatremia in Heart Failure: Practical Considerations
by: Victoriţa Şorodoc, et al.
Published: (2023-01-01)

Systematic Review of Literature on Single-Nucleotide Polymorphisms Within the Oxytocin and Vasopressin Receptor Genes in the Development of Social Cognition Dysfunctions in Individuals Suffering From Autism Spectrum Disorder
by: Krzysztof Maria Wilczyński, et al.
Published: (2019-05-01)

Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle
by: Lauren J. Albee, et al.
Published: (2018-01-01)

Effects of Arginine Vasopressin on musical short-term memory
by: Roni Y. Granot, et al.
Published: (2013-10-01)

Vasopressin receptor antagonists and their role in clinical medicine
by: Girish Narayen, et al.
Published: (2012-01-01)

Oxytocin and arginine vasopressin receptor evolution: implications for adaptive novelties in placental mammals
by: Pamela Paré, et al.

Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1–SERCA2 cascade in H9C2 cells
by: Jieqiong Zhao, et al.
Published: (2020-05-01)

Phosphorylation of CaMK and CREB-Mediated Cardiac Aldosterone Synthesis Induced by Arginine Vasopressin in Rats with Myocardial Infarction
by: Yuan-Sheng Zhai, et al.
Published: (2022-12-01)

Effectiveness of arginine vasopressin for the management of refractory hemorrhagic shock in a patient with autonomic dysreflexia caused by spinal cord injury
by: Tsukasa Shimauchi, et al.
Published: (2018-11-01)

Comparison of natural and artificial vasopressin deficiency: why the latter is lethal?
by: D. Zelena
Published: (2016-05-01)

Regulation of CFTR Expression and Arginine Vasopressin Activity Are Dependent on Polycystin-1 in Kidney-Derived Cells
by: Carolina Monteiro de Lemos Barbosa, et al.
Published: (2016-01-01)

A Synaptically Connected Hypothalamic Magnocellular Vasopressin-Locus Coeruleus Neuronal Circuit and Its Plasticity in Response to Emotional and Physiological Stress
by: Oscar R. Hernández-Pérez, et al.
Published: (2019-03-01)